Continuous twin screw granulation of controlled release formulations with various HPMC grades by Vanhoorne, Valérie et al.
 
 
biblio.ugent.be 
 
The UGent Institutional Repository is the electronic archiving and dissemination platform for all 
UGent research publications. Ghent University has implemented a mandate stipulating that all 
academic publications of UGent researchers should be deposited and archived in this repository. 
Except for items where current copyright restrictions apply, these papers are available in Open 
Access. 
 
This item is the archived peer‐reviewed author‐version of: Continuous twin screw 
granulation of controlled release formulations with various HPMC grades  
Authors: Vanhoorne V., Janssens L., Vercruysse J., De Beer T., Remon J.P., Vervaet C.      
In: International Journal of Pharmaceutics 2016, 511(2): 1048‐1057 
 
To refer to or to cite this work, please use the citation to the published version: 
Vanhoorne V., Janssens L., Vercruysse J., De Beer T., Remon J.P., Vervaet C. (2016) 
Continuous twin screw granulation of controlled release formulations with various HPMC 
grades. International Journal of Pharmaceutics 511 1048‐1057 DOI: 
10.1016/j.ijpharm.2016.08.020  
 
 
 
 
 
 
  
 
  
 
Continuous twin screw granulation of controlled release formulations with various 
HPMC grades 
 
V.Vanhoorne1, L. Janssens1, J. Vercruysse1, T. De Beer2, J.P. Remon1, C. Vervaet1 
1Laboratory of Pharmaceutical Technology, Ghent University (Belgium) 
2Laboratory of Pharmaceutical Process Analytical Technology, Ghent University (Belgium) 
 
Corresponding Author: 
Chris Vervaet 
Ghent University 
Laboratory of Pharmaceutical Technology 
Ottergemsesteenweg 460 
9000 Ghent 
Belgium 
Tel: +32 9 264 80 69 
Fax: +32 9 222 82 36 
E-mail: chris.vervaet@ugent.be 
  
Abstract 
 
HPMC is a popular matrix former to formulate tablets with extended drug release. Tablets with 
HPMC are preferentially produced by direct compression. However, granulation is often 
required prior to tableting to overcome poor flowability of the formulation. While continuous 
twin screw granulation has been extensively evaluated for granulation of immediate release 
formulations, twin screw granulation of controlled release formulations including the dissolution 
behavior of the formulations received little attention. Therefore, the influence of the HPMC 
grade (viscosity and substitution degree) and the particle size of theophylline on critical quality 
attributes of granules (continuously produced via twin screw granulation) and tablets was 
investigated in the current study. Formulations with 20 or 40% HPMC, 20% theophylline and 
lactose were granulated with water at fixed process parameters via twin screw granulation. 
The torque was influenced by the viscosity and substitution degree of HPMC, but was not a 
limiting factor for the granulation process. An optimal L/S ratio was selected for each 
formulation based on the granule size distribution. The granule size distributions were 
influenced by the substitution degree and concentration of HPMC and the particle size of 
theophylline. Raman and UV spectroscopic analysis on 8 sieve fractions of granules indicated 
an inhomogeneous distribution of theophylline over the size fractions. However, this 
phenomenon was not correlated with the hydration rate or viscosity of HPMC. Controlled 
release of theophylline could be obtained over 24 h with release profiles close to zero-order. 
The release of theophylline could be tailored via selection of the substitution degree and 
viscosity of HPMC.  
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C%   Compressibility index 
d50   Median particle size 
ffc   Flowability index 
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V0   Bulk volume 
V1250   Tapped volume 
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a50   median aspect ratio    
d50   median particle size 
GSD   granule size distribution 
PCA   principal component analysis 
PC   principal component 
 
  
1. Introduction 
 
Hydroxypropylmethylcellulose (HPMC) is widely applied in oral, ophtalmic and 
topical pharmaceutical formulations. In oral products, HPMC is applied as binder, 
film coating and hydrophilic matrix former. As matrix former, it sustains drug release 
resulting in a prolonged therapeutic effect, minimization of side effects, reduced 
administration frequency and improved patient compliance. Hydrogen bonding 
between HPMC and water forms a gel layer at the surface of a wetted tablet, 
controlling the drug release via diffusion through and erosion of the highly viscous 
polymer matrix. The matrix forming and drug release mechanisms have been 
thoroughly studied by several research groups [1-3]. HPMC has a polymeric 
backbone of cellulose substituted with hydroxypropyl and methyl groups. The ratio 
of hydroxypropyl and methyl substitutions is referred to as the degree of substitution 
and will determine the characteristics of the polymer (e.g. solubility, hydration rate). 
Additionally commercially available HPMC grades differ with regard to molecular 
weight and therefore viscosity.  
HPMC is the most popular hydrophilic matrix former for production of controlled 
release tablets as it is non-ionic, stable over a broad pH range, enzyme resistant, 
odourless and tasteless, extensively studied and understood, non-toxic and cost-
effective [4-8]. Moreover the available variety of HPMC grades with different 
substitution degrees and viscosities make it a versatile matrix former for controlled 
release of a wide range of drugs with varying solubilities and doses [8]. Tablets with 
HPMC can be produced by direct compression but often granulation is necessary 
[4, 9]. High shear and fluid bed granulation were successfully applied to improve the 
flowability of formulations with HPMC [4, 5, 9, 10-16], often requiring hydro-alcoholic 
granulation liquids as granulation with water yielded lumps as well as fines due to 
the irregular wetting of the formulation.  
Twin screw granulation is an emerging continuous granulation technique that 
can be implemented in a fully continuous from-powder-to-tablet manufacturing line. 
This concept offers economic advantages, improved product quality and a lower 
environmental impact [17, 18, 19, 20]. However, up to now only two studies 
addressed continuous granulation of formulations with HPMC [21, 22]. Whereas 
these studies used the same HPMC grade and investigated the influence of process 
parameters, in current study the impact of formulation variables on critical quality 
attributes of granules and tablets was studied. Three HPMC grades (in two 
concentrations), varying in substitution degree and viscosity, and two theophylline 
grades, varying in particle size, were included in the formulations.  
  
2. Materials and methods 
 
2.1. Materials 
 
Anhydrous theophylline, in a micronized and powdered grade, was used as 
model drug and was kindly donated by BASF (Ludwigshafen, Germany). Three 
HPMC grades (90SH-4000-SR, 90SH-100000-SR and 60SH-4000) were kindly 
donated by ShinEtsu (Tokyo, Japan). The substitution types (according to the USP 
and Ph. Eur.) and viscosities of these HPMC grades are included in Table 1. 
Magnesium stearate (Fagron, Waregem, Belgium) and α-lactose monohydrate 
(Pharmatose 200M, DMV-Fronterra, Veghel, The Netherlands) were used as 
lubricant and filler, respectively.  
 
2.2. Methods 
 
2.2.1. Preparation granules 
 
Theophylline (20% w/w), HPMC (20 or 40% w/w) and lactose were preblended 
in a tumbling mixer (Inversina Bioengineering, Wald, Switzerland) for 10 minutes at 
25 rpm. An overview of the formulations is shown in Table 2. Subsequently they 
were transferred to the loss-in-weight feeder (DDW-MD2-DDSR20, Brabender, 
Duisburg, Germany) of the ConsiGmaTM-1 (GEA Pharma Systems, GEA Pharma 
Systems, Wommelgem, Belgium) system. This system is a laboratory-scale 
continuous granulator with an integrated fluid bed dryer intended for early R&D work. 
The granulation unit consists of a co-rotating twin screw granulator without a die 
plate and has a length-to-diameter ratio of 20/1. The barrel can be divided in a feed 
segment with conveying elements and a work segment where the powder is 
intensively mixed with the granulation liquid by kneading elements. A PT-100 
temperature sensor was integrated in the work segment of the barrel and linked to 
a feedback control system which regulates the temperature in the barrel jacket and 
compensates for temperature increase during the process due to friction. Torque 
was monitored by a built-in torque gauge at 1-second intervals. All torque values 
were smoothed by application of moving average (over a period of 5 
measurements). Water as granulation liquid was pumped into the barrel just before 
the first kneading element via a double liquid addition port (internal diameter 0.8 
mm), injecting granulation liquid on top of each screw. For all experiments the 
distance between liquid addition and the first kneading element was kept constant. 
Granulation of the formulations was performed at constant process parameters 
(screw speed 900 rpm, throughput 10 kg/h, barrel temperature 25 °C) using a fixed 
screw configuration consisting of two kneading blocks with each 6 kneading 
elements at an angle of 60°. This screw configuration was schematically presented 
by Vanhoorne et al. [22]. The liquid-to-solid (L/S) ratio was varied between 0.08 and 
0.18 with intervals of 0.02. After stabilization of torque at least 100 g granules were 
collected at the outlet of the granulator at each L/S ratio, while 1000 g granules was 
collected at an L/S ratio considered optimal for each formulation. The optimal L/S 
ratio (listed in Table 2) was dependent on the HPMC grade and percentage HPMC 
included in the formulation. The granules were tray dried in an oven at 40 °C for 24 
h. After drying, the granules processed with an optimal L/S ratio were milled through 
a 1000 μm grater screen with square impeller at 900 rpm using the Quadro comil 
(U10, Quadro, Ontario, Canada) incorporated in the ConsiGmaTM-25 line. 
 
2.2.2. Preparation of tablets  
 
The milled granules were blended with 0.5% magnesium stearate in a tumbling 
blender for 2 minutes at 49 rpm (T2F, W.A. Bachofen, Basel, Switzerland) before 
tableting. Tablets were prepared in manual mode at a speed of 230 tablets per 
minute on the ModulTM P tablet press (GEA Pharma Systems CourtoyTM, Halle, 
Belgium). The press was equipped with 10 pairs of round flat-faced bevel-edged 
Euro B punches (GEA Pharma Systems, Halle, Belgium) (diameter 12 mm) and an 
overfill cam of 16 mm. The paddles in the feed frame were rotating at 15 and 20 
rpm. Filling depths between 5.75 and 7.50 mm were used, dependent on the density 
of the samples. Tablets were compressed at 7 different main compression pressures 
in order to assess the tabletability of the granules: 60, 110, 150, 190, 260, 330, 410 
MPa after precompression at 15 MPa. Tablets compressed at 190 and 330 MPa 
were selected for friability and dissolution testing. 
 
2.2.3. Characterization methods 
 
2.2.3.1. Laser diffraction 
 
The particle size distributions of all starting materials were measured in 
duplicate by laser diffraction (Mastersizer S long bench, Malvern Instruments, 
Worcestershire, UK) and the average particle size distributions were calculated via 
the Mastersizer 2000 software. The dry dispersion technique was applied using a 
1000 mm lens at a jet pressure of 3.2 bar (Malvern 220 Instruments, Worcestershire, 
UK). The results were expressed as volume diameters d10, d50 and d90. The span 
was calculated as (d90-d10)/d50 and was an indication of the width of the particle size 
distribution. 
 
 
2.2.3.2. Loss on drying 
 
The residual moisture content of the milled granules was determined via loss-
on-drying using a moisture analyzer (Mettler LP16, Mettler-Toledo, Zaventem, 
Belgium) including an infrared dryer and a balance. A sample of 5 g was dried at 
105 °C until the weight was constant for 30 s. 
 
2.2.3.3. Particle size and shape analysis 
 
The granule size and shape of all granules was analyzed before and after milling 
via dynamic image analysis using the QICPICTM system (Sympatec, Clausthal-
Zellerfeld, Germany) equipped with a vibrating feeder system (Vibri/LTM) for 
gravimetrical feeding of the granules. Samples of 20 g were measured in duplicate. 
Averaged granule size distributions are shown, as the measurements were done in 
duplicate and the respective results did not differ from each other. Windox 5 software 
(Sympatec, Clausthal-Zellerfeld, Germany) was used to calculate the median 
granule size (d50) as the equivalent projected circle diameter based on a volume 
distribution. The amounts of fines and oversized granules were defined as the 
fractions <150 µm and >1500 µm, respectively. The yield of the process was defined 
as the percentage of granules between 150 and 1500 µm. The aspect ratio (i.e. the 
ratio of the minimal Ferret diameter to the maximal diameter orthogonal to it) of the 
granules was determined to evaluate the shape of the granules. The median aspect 
ratio (a50) of the granules was calculated by the Windox 5 software. 
For analysis of drug content in the granules by Raman and UV spectroscopy, 
different size fractions of the milled granules were isolated by sieve analysis using 
a Retsch VE 1000 sieve shaker (Haan, Germany). Granules were placed on the 
shaker during 10 min at an amplitude of 2 mm using a series of sieves (150, 250, 
500, 710, 1000, 1400 and 2000 μm). The amount of granules retained on each sieve 
was determined and isolated. 
 
 
2.2.3.4. Flowability testing 
 
The flowability expressed as the flowability index (ffc) of the milled granules was 
measured in duplicate by ring shear testing (Type RST-XS, Dietmar Schulze 
Schüttgutmesstechnik, Wolfenbuttel, Germany). The powders were tested using 
three consolidation stresses (250,  525 and 800 Pa) at a preshear of 1000 Pa. 
Additionally, the compressibility index (C%) was calculated from the bulk and 
tapped densities of the milled granules. The bulk volume (V0) of 30 g milled granules 
was measured in a 100 ml graduated cylinder as well as the tapped volume after 
1250 taps (V1250) in a tapping machine (J. Englesman, Ludwigshafen, Germany). 
Experiments were performed in duplicate. Bulk and tapped densities were calculated 
as 30 g/V0 and 30 g/V1250, respectively. The compressibility index was calculated 
from the bulk (ρi) and tapped (ρf) densities using the following equation: C% = [(ρf - 
ρi)/ ρf]*100. 
 
2.2.3.5. Friability analysis 
 
The granule friability of the milled granules was determined in duplicate using a 
friabilator (PTF E Pharma Test, Hainburg, Germany) at a speed of 25 rpm for 10 
min, by subjecting 10 g (Iwt) of milled granules together with 200 glass beads (mean 
diameter 4 mm) to falling shocks. Prior to determination, the granule fraction <250 
µm was removed to assure the same starting conditions. Afterwards, the glass 
beads were removed and the weight retained on a 250 µm sieve (Fwt) was 
determined. The friability was calculated as [(Iwt – Fwt)/Iwt]*100. 
 
2.2.3.6. Raman spectroscopy 
 
Raman spectroscopy was applied on isolated sieve fractions to evaluate the 
distribution of theophylline over the sieve fractions. Raman spectra (Raman Rxn1, 
Kaiser Optical Systems, Ann Arbor, United States) of the samples were recorded (n 
= 5) using exposure times of 5 s with 3 accumulations. All spectra were recorded 
with a resolution of 4 cm-1. The spectral region between 300 and 1500 cm-1 was 
selected for evaluation. Principal component analysis (PCA) was applied on the 
spectra with Simca 13.0.3 software (Umetrics, Umeå, Sweden). Data were corrected 
by standard normal variate preprocessing and center-scaled prior to analysis. 
Standard normal variate preprocessing was applied to eliminate the additive 
baseline offset variations and multiplicative scaling effects in the spectra which may 
be caused by small variations in distance between the Raman probe and the sample 
and possible differences in product density. 
 
2.2.3.7. UV spectroscopy 
 
The isolated sieve fractions were dissolved in water (1 mg/ml), diluted 20 times 
and measured by UV spectroscopy (UV-1650PC, Shimadzu Benelux, Antwerp, 
Belgium). The theophylline content in these samples was derived from their 
absorbance at 272 nm. 
 
 
2.2.4. Evaluation of the tablets 
 
The hardness, thickness and diameter of the tablets (n = 10) were determined 
using a hardness tester (Type HT 10, Sotax, Basel, Switzerland) and the tensile 
strength of the tablets was calculated according to the formula of Fell and Newton 
[23]:  
Tensile strength = 2F/πdt 
Where F, d and t denote the diametral crushing force, tablet diameter and tablet 
thickness, respectively.  
The tablet friability of tablets compressed at 190 and 330 MPa was determined 
using a friabilator (PTFE, Pharma Test, Hainburg, Germany) as described in the 
European Pharmacopoeia at a speed of 25 rpm for 4 min. The percentage weight 
loss was expressed as the tablet friability.  
Dissolution tests were performed (n = 3) in 900 ml demineralized water using 
the paddle method (VK 7010, Vankel, Cary, NC, USA). The temperature of the 
dissolution medium was maintained at 37 ± 0.5 °C, while the rotation speed was set 
at 100 rpm. Samples of 5 ml were withdrawn after 0.5, 1, 2, 4, 6, 8, 12, 16, 20 and 
24 h. The drug content in these samples was derived from the absorbance of the 
samples at 272 nm using a UV spectrophotometer (UV-1650PC, Shimadzu Benelux, 
Antwerp, Belgium). 
 
3. Results and discussion 
 
Evaluation of the granulation process 
 
3.1.1. Torque 
 
Since HPMC swells upon hydration, excessive torque values might limit the 
processing of formulations with HPMC. Although inclusion of 40% HPMC in the 
formulations resulted in higher torque values compared to 20% HPMC, the torque 
was lower than 10 Nm for all experiments, which was far below the maximal torque 
(20 Nm) tolerated by the granulator.  
Increasing the L/S ratio resulted in higher torque values until a critical L/S ratio 
was reached where torque became independent of L/S ratio. This is illustrated in 
Figure 1 for F9 where the L/S ratio was increased up to 0.18. Reports on the 
influence of L/S ratio of immediate release formulations on torque are contradictory, 
indicating linear or inverse relationships depending on the formulation [24, 25, 26]. 
Nevertheless, the results in current study were compatible with the regime map 
presented by Tu et al. on an immediate release formulation with microcrystalline 
cellulose (MCC), a component also known to swell upon hydration, reporting that 
the torque increased until a critical L/S ratio was reached and then decreased [27]. 
First the torque increased at higher L/S ratios due to interparticle bond formation but 
after reaching a critical L/S ratio over-wetted malleable particles were formed 
resulting in lower torque readings. 
Longer runs (at least 10 min) were performed using the optimized L/S ratio was 
selected for each formulation (Table 2). The torque of these runs was compared to 
evaluate the influence of viscosity and the substitution degree of the HPMC grade 
on torque. The effect of these variables was most obvious with the formulations 
containing 40% HPMC. Inclusion of HPMC grades with a high viscosity and a high 
degree of hydroxypropyl substituents increased the torque. As viscous materials 
caused frictional resistance of the material to flow, the torque during granulation of 
F8 was higher compared to F7 (Figure 2). This is similar to literature reports on high 
torque values recorded during twin screw granulation with viscous liquids [24, 25]. 
Granulation of a formulation with HPMC substitution type 2208 (F7) resulted in 
higher torque values than with HPMC substitution type 2910 (F9) (Figure 2). The 
former type has more hydroxypropyl substituents and consequently swells faster 
upon hydration in the granulation process. This resulted in faster formation of a 
highly viscous gel structure, yielding high torque values. The particle size of the 
theophylline grade did not influence the torque. 
  
3.2. Influence of formulation variables on granule quality 
 
Overall the granule size distribution (GSD) was broad which is a common 
observation for twin screw granulation, independently of the formulation [17, 24, 26, 
27 28, 29, 30, 31, 32, 33, 34]. These multimodal distributions can potentially result 
in segregation during downstream processing and have a negative effect on the 
drying uniformity. Efforts have been made to obtain monomodal GSD after 
continuous granulation through optimization of the feeder performance, screw 
design, binder addition, liquid pump, nozzle design and operation at low filling 
degree [22, 28, 30, 35, 36]. However, for granulation of HPMC bimodal distributions 
were also reported on high shear granulation which was attributed to the specific 
granulation mechanism of HPMC [11]. HPMC grades used as matrix former quickly 
absorb water and develop a gel layer during granulation. This hinders uniform 
distribution of granulation liquid in the powder bed. Moreover the viscous gel layer 
is resistant against shear forces and consequently limits breakage of the granules, 
resulting in a bimodal distribution [11]. Thus, obtaining a monomodal GSD by twin 
screw granulation is even more challenging for controlled release formulations with 
HPMC compared to immediate release formulations. 
The GSD (d50, fines and oversized fraction) was evaluated in function of the L/S 
ratios and formulation parameters (substitution degree, viscosity and concentration 
of HPMC, particle size of theophylline). The d50, fines and oversized fraction in 
function of L/S ratio are shown in Figure 3 and Figure 4. Increasing the L/S ratio 
yielded granules with a higher d50, fewer fines and more oversized granules. The 
formulations with HPMC substitution type 2910 (F3, F6 and F9) required more water 
for efficient granulation compared to HPMC type 2208 (F1 vs. F3, F4 vs. F6 and F7 
vs. F9 in Figure 3). At a specific L/S ratio the granules with HPMC grade 2910 
contained more fines and less oversized granules compared to the granules with 
HPMC grade 2208. This is linked to the higher hydrophilicity and faster polymer 
hydration of HPMC type 2208, which has less methoxy substituents than HPMC type 
2910. This allows a faster interaction with water during twin-screw granulation, 
hence more bonds are formed between water and HPMC type 2208, yielding larger 
granules at a specific L/S ratio.  
The molecular weight (and therefore the viscosity) of the polymers did not 
influence GSD (F1 vs. F2, F4 vs. F5 and F7 vs. F8 in Figure 4). The influence of the 
viscosity of cellulose-ether derivatives during twin screw granulation of immediate 
release formulations was studied in literature by varying the amount of binder in the 
granulation liquid. In these studies more binder resulted in larger granules which 
was linked to the higher binder viscosity [24, 36]. However, the viscosity of cellulose-
ether derivatives used as binders in immediate release formulations is 100 to 
100000-fold lower than the grades used for controlled release purposes. In addition, 
in immediate release applications the polymeric binder is often added to the process 
as an aqueous dispersion (i.e. via the granulation liquid), while HPMC in sustained 
release formulations can only be added dry (i.e. mixed with the other powder 
components prior to the addition of granulation liquid). Hence, the granulation 
behavior of cellulose-ether derivatives as binders in immediate release formulations 
cannot be compared to that of cellulose-ethers used as matrix former in sustained 
release formulations.  
While granule growth was affected by the substitution degree of HPMC during 
twin screw granulation, the viscosity of HPMC and not the substitution degree 
influenced GSD during high shear granulation [9]. This difference is likely due to the 
difference in residence time between continuous (5 – 20 s) and high shear 
granulation (tens of minutes) as the substitution degree (and thus hydration rate) 
only influences granule growth when the contact time between water and polymer is 
short [24, 26, 32, 36].  
Inclusion of a higher HPMC concentration in the formulation required more 
water to obtain granules with a similar GSD. This is illustrated in Figure 5 for the 
formulation with HPMC type 2910 and was attributed to the high water binding 
capacity of HPMC.  
To evaluate the influence of raw material variability on processability, granule 
and tablet critical quality attributes, two theophylline grades (F1-3: micronized, F4-
6: powdered grade) were included in the formulations. The particle size distributions 
of all starting materials were summarized by their d10, d50, d90 and span (Table 2). 
The particle size of micronized theophylline was significantly smaller than of the 
powdered grade. However, the primary particle size of theophylline starting material 
did not influence the GSD of the formulations. This is in agreement with research of 
El Hagrasy et al. on immediate release formulations, reporting limited differences in 
GSD among formulations with different lactose grades at low L/S ratios [32]. At 
higher L/S ratios a direct correlation between the primary particle size of lactose and 
GSD was established by El Hagrasy et al. [32]. Furthermore, Fonteyne et al. linked 
the primary particle size of theophylline to differences in the GSD [37]. In the current 
study the inclusion of a high percentage of HPMC, which in addition to its function 
as matrix former also acts as binder, probably eliminated the effect of primary 
particle size on GSD.  
For each formulation an optimal L/S ratio was selected based on the GSD 
results: yielding granules with less than 10% fines, less than 52% oversized granules 
and a d50 between 1300 and 1600 µm. As the GSD was broad, milling was necessary 
to narrow down the GSD before tableting. Therefore, a large fraction of oversized 
granules was tolerated in these samples. After milling, the samples were further 
analysed with regard to flowability, friability, distribution of theophylline over the 
sieve fractions and finally tableted. The yield of the process before milling varied 
between 40 and 49% which was mainly due to an extensive oversized fraction. This 
fraction was eliminated by milling, resulting in a yield varying between 78 and 86%.   
The median aspect ratios varied between 0.57 and 0.63 (Figure 6). This is 
slightly lower than typically reported for immediate release formulations [17, 21, 24]. 
The aspect ratios of the formulations with HPMC substitution type 2910 were higher 
compared to formulations with HPMC substitution type 2208, although the 
differences were minor. As the viscous gel layer of HPMC type 2910 formed slower 
due to the lower number of hydrophilic substituents, granules containing type 2910 
are more deformable during the granulation process, yielding a higher aspect ratio. 
No correlation between the median aspect ratios and the applied L/S ratio was 
detected.  
Thompson et al. reported the formation of elongated noodle-like granules (3-10 
mm) during granulation with HPMC type 2208, even with formulations containing 
only 5% HPMC. In the current study a similar screw design was used but no 
elongated granules were formed with either HPMC grade. This confirmed previous 
research of our group, studying the influence of process parameters on the 
granulation behaviour of a formulation with HPMC type 2208, where no elongated 
granules were formed [22]. Thus, granule shape was not an issue for granulation of 
formulations with different types of HPMC.  
All granules were classified as passable and easy-flowing according to the C% 
and ffc values, respectively [38]. The friability of the granules was low, varying 
between 8.1 and 13.9 % (friability lower than 30% is considered acceptable, using 
the applied method). 
The content uniformity of theophylline over 8 sieve fractions was evaluated by 
Raman and UV spectroscopy for all formulations. The results of the Raman analysis 
were summarized in a PC 1 vs. PC 2 scores plot of the first and second principal 
components (PC), explaining 54 and 25% of variation in the dataset, respectively 
(Figure 7). The spectra of the fines fraction (< 150 µm) were clustered in the negative 
part of PC 2 while the spectra of fractions 150 - 250 µm and 250 - 500 µm were 
clustered in the positive part of PC 2. The other size fractions (500 - > 2000 µm) 
were distributed homogeneously over the PC 1 vs. PC 2 scores plot. Comparison of 
the spectra of lactose and theophylline to the loading plot of PC 1 and PC 2 learned 
that PC 1 represented variation due to baseline offset variations while the maxima 
and minima of the PC 2 loading plot were characteristic for theophylline and lactose, 
respectively (Figure 8). This signified that theophylline was underdosed in the fines 
fraction (on average 15% less theophylline) and overdosed in the fractions 150 - 250 
µm and 250 - 500 µm (an excess of 7 and 6%, respectively). The uneven distribution 
of theophylline over the size fractions was present in all formulations, independently 
of the viscosity and substitution degree of HPMC. Comparable observations were 
made after batch granulation of immediate release formulations [39, 40]. These 
studies pointed at differences in primary particle size between drug and fillers to 
explain preferential granule growth and consequently inhomogeneous drug 
distribution over the size fractions. Despite the similar primary particle size of lactose 
and powdered theophylline in formulations F4-6, theophylline was not evenly 
distributed over the size fractions of these formulations. This was also observed by 
Fonteyne et al. after continuous granulation of an immediate release formulation 
[37]. However, no explanation was found for the observations. Thorough 
characterization of the starting materials (e.g. solubility, solubility rate, wettability) 
could help to reveal the granulation mechanism leading to uneven API distribution 
over the size fractions of granules produced by twin screw granulation.  
 
 
3.3. Influence of the formulation variables on tablet quality 
 
The tensile strength of the milled formulations tableted at 7 main compression 
pressures was measured. The particle size distributions and moisture content of the 
different formulations were similar and could not bias the comparison of the 
formulations. A linear relationship between tensile strength and main compression 
pressure was established for all formulations. No differences in tensile strength were 
detected between the formulations containing 20% HPMC, whereas the viscosity 
and substitution degree of HPMC influenced the tensile strength of the formulations 
containing 40% HPMC (Figure 9). F7, containing an HPMC grade with a lower 
viscosity, showed a lower tensile strength than F8, containing an HPMC grade with 
a higher viscosity. Similar observations were made after high shear granulation of 
HPMC with different viscosities [9]. This was attributed to the stronger plastic 
deformation during compression of HPMC grades with a high viscosity [9]. 
Comparing F7 (containing HPMC type 2208) and F9 (containing HPMC type 2910), 
it is clear that the substitution degree of HPMC also affected the tensile strength of 
formulations containing 40% HPMC. HPMC type 2208 contains more hydrophilic 
substituents that can form hydrogen bonds during compression, yielding harder 
tablets. This in agreement with research on the compaction behavior of HPMC with 
different substitution degrees after direct compression and batch granulation [4, 9, 
41, 42, 43, 44]. The particle size of theophylline starting material did not influence 
the tensile strength.  
Considering the linear relation between tensile strength and main compression 
pressure, the friability of tablets compressed at an intermediate (190 MPa) and high 
(330 MPa) main compaction pressures was determined. The friability of all tablets 
was low, varying between 0.05 and 0.16%. The tablets compressed at a higher main 
compression pressure were harder and consequently less friable. No correlation 
between HPMC or theophylline grade and the friability of the corresponding tablets 
was detected. 
The influence of viscosity and substitution degree of HPMC on the drug release 
rate after direct compression and batch granulation was already extensively studied 
[4, 9, 12]. However, a comparative study between twin screw granulation and high 
shear granulation demonstrated that granules produced by twin screw granulation 
were denser and that the drug release rate from tablets derived from these dense 
granules was slower [34]. Therefore the influence of viscosity and substitution 
degree of HPMC on drug release was investigated after twin screw granulation in 
the current study. 
The release of tablets compressed at 190 MPa and 330 MPa was measured 
but the main compression pressure did not significantly influence the release, a 
similar observation was already reported after high shear granulation [43]. Inclusion 
of 20% HPMC type 2208 resulted in controlled release of theophylline over 24 h, 
while complete drug release was obtained after 16 h with 20% HPMC type 2910 (F4 
vs. F6 in Figure 10). The viscosity of HPMC also influenced the release rate of 
theophylline, a higher viscosity resulting in a slightly slower release (F4 vs F5 in 
Figure 10). At 40% polymer load, the drug release was only affected by the viscosity 
of HPMC and not by its substitution degree. Incomplete release (80%) of 
theophylline was obtained after 24 h with the highest viscosity HPMC grade (F8), 
while F7 (HPMC type 2208) and F9 (HPMC type 2210) showed identical dissolution 
profiles and complete release after 24 h. These dissolution profiles also approached 
zero-order kinetics. Thus, at low polymer load the faster hydration of HPMC type 
2208 resulted in a faster formation of the matrix and at both polymer loads the higher 
viscosity of HPMC formed a more tortuous and resistant barrier to diffusion and 
erosion, resulting in slower release rates. These results are in accordance with 
dissolution studies of HPMC after direct compression and batch granulation [4, 9, 
12, 14, 41, 43, 45, 46]. The particle size of theophylline starting material did not 
influence the release of the formulations. 
 
4. Conclusions 
 
HPMC was identified as versatile matrix former for manufacturing of controlled 
release formulations via twin screw granulation using water as granulation liquid. 
The torque during processing was linked to viscosity and hydration rate of HPMC, 
but the recorded torque values did not limit the process. HPMC type 2910 required 
more water during granulation to obtain a similar granule size distribution compared 
to HPMC type 2208 which was attributed to its lower hydrophilicity. Although 
theophylline was not homogenously distributed over the size fractions (with a lower 
theophylline content in the fines fraction), this phenomenon was not correlated to 
the hydration rate or viscosity of HPMC. The release of theophylline was 
independent of the compression pressure but could be steered by the viscosity and 
substitution degree of HPMC to obtain sustained release over 24 h. 
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Table 1 Overview and characterization of the starting materials. 
 
Product Substi
-tution 
typea 
Viscosity 
(mPa*s) 
d10 
(µm) 
d50 
(µm) 
d90 
(µm) 
span True 
density 
(g/cm³) 
HPMC Metolose 90SH-4000-
SR 
2208 4000 18.8 80.4 208.5 2.4 1.32 
HPMC Metolose 90SH-100000-
SR 
2208 100000 14.5 49.7 287.6 5.5 1.32 
HPMC Metolose 60SH-4000 2910 4000 16.6 42.6 253.2 5.6 1.29 
α-lactose monohydrate  - - 6.6 41.4 113.8 2.6 1.46 
Micronized theophylline - - 0.52 8.6 25.6 2.9 1.49 
Powdered theophylline - - 4.5 41.7 95.0 2.2 1.48 
 
  
aSubstitution type according to the USP and Ph. Eur. 
Table 2 Composition of the granulated formulations. 
 
Formulation 
Theophylline (%) HPMC (substitution type – viscosity) lactose 
Optimized 
L/S ratio 
micronized powdered 2208-4000 
2208-
100000
2910-
4000  
F1 20 - 20 - - 60 0.10 
F2 20 - - 20 - 60 0.10 
F3 20 - - - 20 60 0.12 
F4 - 20 20 - - 60 0.10 
F5 - 20 - 20 - 60 0.10 
F6 - 20 - - 20 60 0.12 
F7 - 20 40 - - 40 0.12 
F8 - 20 - 40 - 40 0.12 
F9 - 20 - - 40 40 0.16 
 
  
Table 3 Overview of the bulk and tapped density, compressibility index (C%), friability 
and flowability index (ffc) of the milled granules. 
 
Formulation Bulk 
density 
(g/ml) 
Tapped 
density 
(g/ml) 
C% Friability 
(%) 
ffc 
F1 0.47 0.62 23.1 11.5 5.6 
F2 0.48 0.60 20.5 7.7 5.2 
F3 0.50 0.62 20.5 13.9 6.1 
F4 0.49 0.61 20.2 11.2 5.2 
F5 0.45 0.60 24.4 8.9 4.4 
F6 0.49 0.63 21.6 8.1 6.5 
F7 0.42 0.57 25.6 11.9 4.4 
F8 0.40 0.54 26.4 8.5 4.3 
F9 0.41 0.53 22.7 9.2 5.4 
 
 
Figure 1 Torque profiles in function of L/S ratio for formulation F9. 
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Figure 2  Torque profiles of F7, F8 and F9 granulated with optimized L/S ratios. 
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Figure 3  Influence of HPMC substitution degree on granule size distribution: d50, fines fraction and oversized fraction of F1 and F3 (formulations with 
micronized theophylline and 20% HPMC), F4 and F6 (formulations with powdered theophylline and 20% HPMC) and F7 and F9 (formulations 
with powdered theophylline and 40% HPMC) as a function of the applied L/S ratio. 
 
 
Figure 4  Influence of HPMC viscosity on granule size distribution: d50, fines fraction and oversized fraction of F1 and F2 (formulations with micronized 
theophylline and 20% HPMC), F4 and F5 (formulations with powdered theophylline and 20% HPMC) and F7 and F8 (formulations with 
powdered theophylline and 40% HPMC) as a function of the applied L/S ratio. 
 
 
 
 
Figure 5 Influence of HPMC concentration on granule size distribution: d50, fines fraction and oversized fraction of F6 and F9, containing 20 and 40% 
HPMC, respectively. 
 
 
 
Figure 6 Aspect ratios at varying L/S ratios. 
 
Figure 7 PC1 vs. PC2 scores plot obtained after PCA analysis on 8 sieve fractions of all formulations. 
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Figure 8 Raman spectra of pure lactose and theophylline and loading plot of PC 2 after 
PCA analysis. 
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Figure 9 Tabletability of (A) F4 - 6 (containing 20% HPMC and 20% powdered theophylline) and (B) F7 - 9 (containing 40% HPMC and 
20% powdered theophylline). 
 
 
0
1
2
3
4
5
0 100 200 300 400
T
e
n
s
i
l
e
 
s
t
r
e
n
g
t
h
 
(
M
P
a
)
Main compression pressure (MPa)
F7 F8 F9
0
1
2
3
4
5
0 200 400
T
e
n
s
i
l
e
 
s
t
r
e
n
g
t
h
 
(
M
P
a
)
Main compression force (MPa)
F4 F5 F6
A B
36 
 
 
 
Figure 10 Dissolution profiles of (A) F4 - 6 (containing 20% HPMC and 20% powdered theophylline) and (B) F7 - F9 (containing 40% 
HPMC and 20% powdered theophylline). 
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